Relativity Acquisition Corp. does not have significant operations. It focuses on effecting a capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the cannabis industry. The company was incorporated in 2021 and is based in Las Vegas, Nevada. Relativity Acquisition Corp. operates as a subsidiary of Relativity Acquisition Sponsor LLC.
IPO Year: 2022
Exchange: NASDAQ
Date | Price Target | Rating | Analyst |
---|
4 - Relativity Acquisition Corp (0001860484) (Issuer)
SC 13G - Relativity Acquisition Corp (0001860484) (Subject)
SC 13G/A - Relativity Acquisition Corp (0001860484) (Subject)
SC 13G/A - Relativity Acquisition Corp (0001860484) (Subject)
SC 13G/A - Relativity Acquisition Corp (0001860484) (Subject)
SC 13G/A - Relativity Acquisition Corp (0001860484) (Subject)
SC 13D - Relativity Acquisition Corp (0001860484) (Subject)
NEW YORK, May 6, 2024 /PRNewswire/ -- Relativity Acquisition Corp. (NASDAQ:RACY) (the "Company") today announced that, on April 30, 2024, the Company received a determination letter (the "Letter") from the Nasdaq Listing Qualifications staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating that Staff had determined an additional basis to delist the Company's securities from The Nasdaq Stock Market. The Staff's determination was based upon the Company's non-compliance with the requirements set forth in Listing Rule 5250(c)(1), requiring the timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Staff's determination was base
NEW YORK, NY,, April 29, 2024 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (NASDAQ:RACY) (the "Company") today announced that, on April 23, 2024, the Company received a determination letter (the "Letter") from the Nasdaq Listing Qualifications staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating that Staff had determined to delist the Company's securities from The Nasdaq Stock Market. The Staff's determination was based upon the Company's non-compliance with the requirements set forth in Listing Rule 5250(f), requiring the payment of all applicable fees as described in the Rule 5900 series. The Staff's determination was based on the Company's unpaid past due balance
New York, NY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. ("Relativity") (NASDAQ:RACY) announced today that it had extended the date by which it has to consummate a business combination from November 15, 2023 to February 15, 2024 (the "Extension"). The Extension is the second of two three-month extensions permitted under Relativity's governing documents. In accordance with Relativity Acquisition Sponsor LLC's request and with Relativity's governing documents, an aggregate amount of $1,000.00 from Relativity's working capital was deposited into its trust account for its public stockholders on November 9, 2023. The Extension provides Relativity with additional time to comp
New York, NY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. ("Relativity") (NASDAQ:RACY) announced today that a confidential submission was made to the Securities and Exchange Commission ("SEC"), for receipt by the SEC on August 14, 2021, of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination (the "Business Combination") with SVES LLC, SVES GO, LLC, SVES CP LLC and SVES Apparel LLC (collectively, "SVES"), an off-price apparel distribution company based in Florida. About SVES SVES is a leading wholesale distributor of discount and off-price fashion. SVES delivers differentiat
New York, NY, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. ("Relativity") (NASDAQ:RACY) announced today that it had extended the date by which it has to consummate a business combination from August 15, 2023 to November 15, 2023 (the "Extension"). The Extension is the first of two three-month extensions permitted under Relativity's governing documents. In accordance with Relativity Acquisition Sponsor LLC's request and with the Relativity's governing documents, an aggregate amount of $1,000.00 from Relativity's working capital was deposited into its trust account for its public stockholders on August 3, 2023. The Extension provides Relativity with additional time to comp
SVES has entered into a business combination agreement with Relativity Acquisition Corp. (NASDAQ:RACY)The combined company, which will be named SVES, Inc., will have an implied Pro-forma enterprise value of approximately $707.25 million, assuming no further redemptions by Relativity's public stockholders prior to the business combination NEW YORK, NY, Feb. 13, 2023 (GLOBE NEWSWIRE) -- SVES LLC, SVES GO, LLC, SVES CP LLC and SVES Apparel LLC (collectively, "SVES" or the "Company"), an Off-price Apparel distribution company based in Florida, and Relativity Acquisition Corp. (NASDAQ:RACY) ("Relativity"), a special purpose acquisition company, today announced they have entered into a d
NEW YORK, NY, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (NASDAQ:RACY) (the "Company") announced today that, on January 12, 2023, the Company received a determination letter (the "Letter") from the Nasdaq Listing Qualifications staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company was not in compliance with the requirements of the Nasdaq Listing Rules set forth in (i) Listing Rule 5450(b)(2)(A), requiring a minimum of $50 million Market Value of Listed Securities, (ii) Listing Rule 5450(b)(2)(B), requiring a minimum 1,100,000 Publicly Held Shares, and (iii) Listing Rule 5450(b)(2)(C), requiring a minimum of $15 million in Market Value
NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that the trading halt status in Relativity Acquisition Corp. (NASDAQ:RACY, RACYU and RACYW))) was changed to "additional information requested" from the company. Trading in the company's securities had been halted on January 11, 2023 at 17:14:36 Eastern Time for "news dissemination" at last sale prices of $12.28 (NASDAQ:RACY), $12.99 (NASDAQ:RACYU), $0.0471 (NASDAQ:RACYW). Trading will remain halted until Relativity Acquisition Corp.has fully satisfied Nasdaq's request for additional information. For news and additional information about the company, please contact the company directly or check u
NT 10-K - Relativity Acquisition Corp (0001860484) (Filer)
8-K - Relativity Acquisition Corp (0001860484) (Filer)
425 - Relativity Acquisition Corp (0001860484) (Subject)
8-K - Relativity Acquisition Corp (0001860484) (Filer)
8-K - Relativity Acquisition Corp (0001860484) (Filer)
DEF 14A - Relativity Acquisition Corp (0001860484) (Filer)
PRE 14A - Relativity Acquisition Corp (0001860484) (Filer)
8-K - Relativity Acquisition Corp (0001860484) (Filer)
DEF 14A - Relativity Acquisition Corp (0001860484) (Filer)
8-K - Relativity Acquisition Corp (0001860484) (Filer)
Relativity Acquisition Corp. ("Relativity") (NASDAQ:RACY) announced today that it had extended the date by which it has to consummate a business combination from November 15, 2023 to February 15, 2024 (the "Extension"). The Extension is the second of two three-month extensions permitted under Relativity's governing documents. In accordance with Relativity Acquisition Sponsor LLC's request and with Relativity's governing documents, an aggregate amount of $1,000.00 from Relativity's working capital was deposited into its trust account for its public stockholders on November 9, 2023. The Extension provides Relativity with additional time to complete its business combination.As previously announ
Relativity Acquisition Corp. ("Relativity") (NASDAQ:RACY) announced today that it had extended the date by which it has to consummate a business combination from August 15, 2023 to November 15, 2023 (the "Extension"). The Extension is the first of two three-month extensions permitted under Relativity's governing documents. In accordance with Relativity Acquisition Sponsor LLC's request and with the Relativity's governing documents, an aggregate amount of $1,000.00 from Relativity's working capital was deposited into its trust account for its public stockholders on August 3, 2023. The Extension provides Relativity with additional time to complete its business combination. As previously anno
SVES has entered into a business combination agreement with Relativity Acquisition Corp. (NASDAQ:RACY) The combined company, which will be named SVES, Inc., will have an implied Pro-forma enterprise value of approximately $707.25 million, assuming no further redemptions by Relativity's public stockholders prior to the business combination NEW YORK, NY, Feb. 13, 2023 (GLOBE NEWSWIRE) -- SVES LLC, SVES GO, LLC, SVES CP LLC and SVES Apparel LLC (collectively, "SVES" or the "Company"), an Off-price Apparel distribution company based in Florida, and Relativity Acquisition Corp. (NASDAQ:RACY) ("Relativity"), a special purpose acquisition company, today announced they have entered into a defin
Relativity Acquisition Corp. (NASDAQ:RACY) (the “Company”) announced today that, on January 12, 2023, the Company received a determination letter (the “Letter”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the requirements of the Nasdaq Listing Rules set forth in (i) Listing Rule 5450(b)(2)(A), requiring a minimum of $50 million Market Value of Listed Securities, (ii) Listing Rule 5450(b)(2)(B), requiring a minimum 1,100,000 Publicly Held Shares, and (iii) Listing Rule 5450(b)(2)(C), requiring a minimum of $15 million in Market Value of Publicly Held Shares. In addition, the Letter
Gainers Broadwind Inc (NASDAQ:BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine manufacturer. Lipella Pharmaceuticals Inc (NASDAQ:LIPO) gained 63.2% to $5.06 after the company announced top line results of its Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis. Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 53.1% to $3.17 after adding more than 27% during regular market hours on Tuesday. According to a Wall Street Journal report citing people familiar with the matter, Bed Bath & Beyond has brought on consulting firm AlixP
Gainers Hoth Therapeutics, Inc. (NASDAQ:HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Quotient Limited (NASDAQ:QTNT) shares jumped 124% to $0.5382 after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market. Baudax Bio, Inc. (NASDAQ:BXRX) climbed 65.8% to $3.8150 after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Palisade Bio, Inc. (NASDAQ:PALI) gained 52% to $2.76. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction i